Ascentage Pharma Group International (HK:6855) has released an update.
Ascentage Pharma Group International has officially announced the composition of its board of directors and three key board committees. The board is chaired by Executive Director Dr. Yang Dajun, with a mix of non-executive and independent non-executive directors including Dr. Wang Shaomeng, Dr. Lu Simon Dazhong, Mr. Ye Changqing, Mr. Ren Wei, and Dr. David Sidransky. The announcement details the members and chairpersons of the Audit, Remuneration, and Nomination Committees, crucial for the company’s governance.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.
